tags:: paper, confirmed
link:: [LINK](https://www.frontiersin.org/articles/10.3389/fimmu.2020.594212/full)
authors:: Zhou P, Chen D, Zhu B, Chen W, Xie Q, Wang Y, Tan Q, Yuan B, Zuo X, Huang C, Zhu H, Li G
n:: 9
dose-cgy:: 60
fractionation:: 10
time-post-rt:: within a week
disease-site:: lung cancer
pub-date:: 2021-01-21
tissue-pre-rt:: CT guided bx -1wk
tissue-post-rt:: CT guided bx +<1wk
deg-comparison:: paired pre/post same patient

- ### Demographics
	- Thirteen patients aged 43â€“68 years were included. They had histologically documented malignant tumor, recurrent or metastatic; World Health Organization (WHO) performance status score of 0 to 2; life expectancy of at least 3 months at day 1; and indication for local radiotherapy. Four patients had metastatic lung tumor from colorectal carcinoma (CRC), seven had NSCLC, one had metastatic esophageal carcinoma in the lungs, and one had metastatic cervical cancer in the lungs.
	  id:: 694c420a-68b2-40cd-907b-a498e8747f84
- ### Samples
	- Computed tomography-guided puncture biopsy of the lung deposit was performed a week before SBRT.
	- Lung targeted tumors received 60 Gy irradiation in 10 fractions
	- The second samples of irradiated tumors and peripheral white blood cells were collected within a week after radiotherapy in the same manner as the first collection.